INTERCEPT PHARMACEUTICALS, INC. (21)
Browse by Contract Category
Contracts
-
Retirement and Consulting Agreement by and between Intercept Pharmaceuticals, Inc. and Mark Pruzanski, M.D., dated December 9, 2020
(Filed With SEC on December 10, 2020)
-
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors
(Filed With SEC on August 10, 2020)
-
Letter Agreement, dated October 25, 2019, between the Registrant and Sumitomo Dainippon Pharma Co., Ltd
(Filed With SEC on February 25, 2020)
-
Third Amendment to Lease, dated November 1, 2019, between the Registrant and Legacy Yards Tenant LP
(Filed With SEC on November 5, 2019)
-
Amended and Restated Employment Agreement by and between Intercept Pharmaceuticals, Inc. and Jerome Durso, dated December 9, 2020
(Filed With SEC on December 10, 2020)
-
Employment Agreement, effective June 20, 2015, between the Registrant and Richard Kim
(Filed With SEC on August 10, 2020)
-
Form of Stock Option Grant Notice and Agreement for Directors
(Filed With SEC on August 10, 2020)
-
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants
(Filed With SEC on February 25, 2020)
-
Employment Agreement, effective November 19, 2019, between the Registrant and Jason Campagna
(Filed With SEC on February 25, 2020)
-
Form of Performance Stock Unit Grant Notice and Agreement
(Filed With SEC on February 25, 2020)
-
Form of Stock Option Grant Notice and Agreement for Employees and Consultants
(Filed With SEC on February 25, 2020)
-
Description of Securities of the Registrant
(Filed With SEC on February 25, 2020)
-
Employment Agreement, effective February 6, 2018, between the Registrant and Gail Cawkwell
(Filed With SEC on August 8, 2019)
-
Employment Agreement, effective January 22, 2018, between the Registrant and Ryan Sullivan
(Filed With SEC on August 8, 2019)
-
Second Supplemental Indenture, dated as of May 14, 2019, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00%...
(Filed With SEC on May 14, 2019)
-
Securities Purchase Agreement, dated May 8, 2019, between Intercept Pharmaceuticals, Inc. and Samsara BioCapital, L.P
(Filed With SEC on May 14, 2019)
-
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies...
(Filed With SEC on May 14, 2019)
-
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,...
(Filed With SEC on May 14, 2019)
-
Form of Restricted Stock Unit Grant Notice and Agreement for Employees and Consultants
(Filed With SEC on May 8, 2019)
-
Form of Performance Stock Unit Grant Notice and Agreement
(Filed With SEC on May 8, 2019)
-
Form of Stock Option Grant Notice and Agreement for Employees and Consultants
(Filed With SEC on May 8, 2019)